The Global Medical Device Cleaning Market is forecasted to achieve 6.75% CAGR by 2032, as per DelveInsight

10 February 2026
Medical-Device-Cleaning-Market
Medical-Device-Cleaning-Market

DelveInsight’s latest assessment indicates that the global medical device cleaning market is set to experience steady growth, driven by the rising number of surgical procedures, increasing prevalence of healthcare-associated infections (HAIs), and expanding hospital admission rates worldwide. As surgical volumes continue to rise, the importance of thorough cleaning and sterilization of medical instruments has become paramount to minimize infection risks and ensure patient safety.

The growing burden of HAIs has pushed infection prevention to the forefront of healthcare priorities, accelerating demand for advanced cleaning and disinfection solutions. In parallel, the global increase in hospitalizations particularly among elderly populations and patients with chronic diseases has led to higher utilization of medical devices, reinforcing the need for effective and reliable cleaning technologies. Collectively, these factors are expected to fuel market expansion during the 2025–2032 forecast period.

To know more about why North America is leading the market growth in the Medical Device Cleaning market, get a snapshot of the report Medical Device Cleaning Market Trends

https://www.delveinsight.com/sample-request/medical-device-cleaning-market

Medical Device Cleaning Market Overview

Medical device cleaning involves the removal of blood, organic residues, microorganisms, and other contaminants from medical instruments prior to sterilization or reuse. This process plays a critical role in infection control, regulatory compliance, and the preservation of device functionality. Cleaning methods may include manual cleaning, ultrasonic systems, automated washer-disinfectors, and specialized enzymatic or non-enzymatic detergents. Proper cleaning serves as the foundational step in ensuring safe and effective medical device reprocessing.

According to DelveInsight’s analysis, the medical device cleaning market is projected to grow at a CAGR of approximately 6.75% between 2025 and 2032.

Medical Device Cleaning Market Insights and Regional Outlook

From a regional perspective, North America is expected to maintain its leading position in the global medical device cleaning market. This dominance is attributed to a high volume of surgical procedures, an expanding patient population with complex healthcare needs, and a growing incidence of hospital-acquired infections. Additional growth drivers include a well-established healthcare infrastructure, strong regulatory oversight, increasing government support, rapid adoption of innovative technologies, and the presence of major industry players across the region.

Which MedTech key players in the Medical Device Cleaning market are set to emerge as the trendsetter explore @ Key Medical Device Cleaning Companies

Recent Developments Shaping the Medical Device Cleaning Market

  • In May 2024, Diversey (a Solenis company) introduced Oxivir® Three 64 Next-Generation AHP® Concentrate Disinfectant Cleaner, strengthening its healthcare infection prevention portfolio.
  • In June 2023, Parker Laboratories Inc. received FDA approval for Tristel ULT, a high-level disinfectant designed for ultrasound applications.

Such innovations and regulatory milestones are expected to significantly accelerate market growth over the forecast period.

Medical Device Cleaning Competitive Landscape and Market Dynamics

The medical device cleaning market is characterized by the increasing adoption of automated cleaning and disinfection systems. For instance, in June 2023, CS Medical® obtained FDA clearance for its Ethos® Automated Ultrasound Probe Cleaner Disinfector, the first system in North America to offer integrated cleaning and high-level disinfection for both endocavity and surface ultrasound probes. These advancements are anticipated to boost revenue growth within the automatic cleaning segment and contribute meaningfully to overall market expansion.

Key companies operating in the market include Getinge AB, STERIS plc., Advanced Sterilization Products, Ruhof Corporation, Alconox Inc., Ecolab, 3M, PAUL HARTMANN AG, Sotera Health, GAMA Healthcare Ltd., and Novozymes, among others.

Scope of the Medical Device Cleaning Market Report

  • Geographic Coverage: Global
  • Study Period: 2022–2032
  • Segmentation:
    • By Detergent Type: Enzymatic, Non-Enzymatic
    • By Process: Pre-cleaning, Manual Cleaning, Automatic Cleaning
    • By Disinfection Level: High, Intermediate, Low
    • By Application: Endoscopes, Surgical Instruments, Others
    • By Region: North America, Europe, Asia-Pacific, Rest of the World

The report also includes Porter’s Five Forces analysis, product profiles, case studies, key opinion leader (KOL) insights, and analyst perspectives, offering a comprehensive view of the evolving medical device cleaning market landscape.

Interested in knowing how the Medical Device Cleaning market will grow by 2032? Click to get a snapshot of the Medical Device Cleaning Market Analysis

About DelveInsight

DelveInsight is a leading healthcare business consulting and market research firm dedicated exclusively to the life sciences sector. The company partners with pharmaceutical and biotech organizations to deliver end-to-end solutions that enhance performance, support strategic decision-making, and drive sustainable business growth through data-driven insights and practical consulting expertise.

Leave a Reply

Your email address will not be published.

Don't Miss

Tracheostomy Products Market Poised for Robust Growth, Expected to Expand at ~4% CAGR Through 2032 Driven by Increasing Global Demand and Technological Innovation | DelveInsight

DelveInsight’s Tracheostomy Products Market Insights Report 2032 provides the current and forecast
FDA Orphan Drug Designation

Lantern Pharma’s LP-284 Achieves Third FDA Orphan Drug Designation for Soft Tissue Sarcomas

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage artificial intelligence-driven biopharmaceutical